{"id":49143,"date":"2022-10-04T17:01:46","date_gmt":"2022-10-04T15:01:46","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-downstream-processing-market-report-to-2030-increasing-demand-for-biopharmaceuticals-as-downstream-processing-plays-a-key-role-in-providing-pure-biopharmaceutical-products-is-driving-growth\/"},"modified":"2022-10-04T17:01:46","modified_gmt":"2022-10-04T15:01:46","slug":"global-downstream-processing-market-report-to-2030-increasing-demand-for-biopharmaceuticals-as-downstream-processing-plays-a-key-role-in-providing-pure-biopharmaceutical-products-is-driving-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-downstream-processing-market-report-to-2030-increasing-demand-for-biopharmaceuticals-as-downstream-processing-plays-a-key-role-in-providing-pure-biopharmaceutical-products-is-driving-growth\/","title":{"rendered":"Global Downstream Processing Market Report to 2030 – Increasing Demand for Biopharmaceuticals as Downstream Processing Plays a Key Role in Providing Pure Biopharmaceutical Products is Driving Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Downstream Processing Market By Technology, By Product, By System, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nAccording to this report the Downstream Processing Market Size at $21.8 billion in 2020, and is estimated to reach $92.0 billion by 2030, growing at a CAGR of 13.5% from 2021 to 2030.\n<\/p>\n

\nDownstream processing refers to the recovery and purification of biosynthetic products, particularly pharmaceuticals, from natural sources such as animal or plant tissue or fermentation broth. It is an essential step in the manufacture of pharmaceuticals such as antibiotics, hormones (e.g., insulin and human growth hormone), antibodies (e.g., infliximab and abciximab) and vaccines; antibodies and enzymes used in diagnostics; industrial enzymes; and natural fragrance and flavor compounds. Downstream processing is usually considered a specialized field in biochemical engineering.\n<\/p>\n

\nThe key factors that drive the growth of the market are increase in demand for biopharmaceuticals as downstream processing plays a key role in providing pure biopharmaceutical products. In addition, rise in R&D expenditure for biopharmaceutical products majorly drive the growth of the market.\n<\/p>\n

\nFurthermore, rise in adoption of single-use systems, low risk of product cross contamination and cost-effectiveness are the key factors anticipating the growth of market in upcoming years. In addition, single-use system in downstream processing is highly efficient and cost-effective, which attract pharmaceutical manufacturers to adopt disposable bioprocessing products drive the growth of the market in upcoming years. However, dearth and shortage of skilled bioprocess engineers is expected to restrain the market growth in upcoming years. Moreover, untapped markets such as China and India, offer profitable opportunities to expand this market.\n<\/p>\n

\nThe downstream processing market is segmented on the basis of technique, product, system application, end user, and region. By technique, it is categorized into purification, separation, and clarification\/concentration. Depending on product, it is classified into chromatography columns and resins, filters, membrane absorbers, and other products. By system, it is bifurcated into single use system and re-usable system. By application, it is divided into monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. By end user, it is categorized into biopharmaceutical manufacturers, and contract manufacturing organizations (CMOs).\n<\/p>\n

\nKey Benefits For Stakeholders<\/strong>\n<\/p>\n